A modified adenovirus can transfect cochlear hair cells in vivo without compromising cochlear function

Area of Science:

• Ototolaryngology
• Gene Therapy
• Molecular Biology

Background:

• Cochlear hair cell dysfunction is a primary cause of hearing loss.
• Developing safe and effective gene delivery methods for the cochlea is critical for therapeutic interventions.
• Adenovirus vectors are being explored for in vivo gene transduction in the inner ear.

Purpose of the Study:

• To evaluate the efficacy and safety of two types of adenovirus vectors for gene delivery to guinea pig cochlear hair cells.
• To assess the ototoxic effects of these viral vectors on cochlear function.
• To establish a reliable in vivo gene transfer method for the adult guinea pig cochlea.

Main Methods:

• Replication-deficient (E1(-), E3(-)) and replication-defective (E1(-), E3(-), pol(-)) adenoviruses carrying the beta-galactosidase gene were used for transduction.
• Gene delivery was performed in vivo into the scala tympani of adult guinea pigs.
• Distortion product otoacoustic emissions were measured to monitor outer hair cell function and assess ototoxicity.

Main Results:

• The (E1(-), E3(-)) adenovirus vectors compromised cochlear function.
• The (E1(-), E3(-), pol(-)) adenoviral vectors successfully transduced over 80% of cochlear hair cells.
• No loss of cochlear function was observed with the (E1(-), E3(-), pol(-)) vectors, indicating a lack of ototoxicity.

Conclusions:

• Replication-defective (E1(-), E3(-), pol(-)) adenoviral vectors are a safe and effective tool for gene transfer in the adult guinea pig cochlea.
• This vector system holds promise for gene replacement therapies for inherited deafness and otoprotective strategies.
• The developed in vivo gene transfer technique can be utilized to study gene function in normal cochlear physiology.